OSL oncosil medical ltd

Ann: Half Yearly Report and Accounts, page-3

  1. 13,412 Posts.
    lightbulb Created with Sketch. 1205
    The message cannot be any clearer, am I missing something here?

    "“In anticipation of a positive CE Mark decision, we also began laying the foundations to support commercialisation activities in the EU. This included meetings with key hospitals across the region, enhanced logistical arrangements in preparation for commercial shipment and development of a promotional campaign for Health Care Professionals to be commenced post CE Mark approval.”

    “Noting that all clinical, technical and statistically concerns previously raised by the Clinical Oversight Committee have been closed out since October 2019, we remain confident of a positive CE Mark approval for the OncoSil™ device. We will update the market on developments on this front.”




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.010(0.86%)
Mkt cap ! $21.74M
Open High Low Value Volume
$1.17 $1.17 $1.14 $80.47K 69.48K

Buyers (Bids)

No. Vol. Price($)
1 2150 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.